Crossmark

Icosapent-Ethyl: Welche Patienten profitieren?

Crossref DOI link: https://doi.org/10.1007/s15006-021-9997-1

Published Online: 2021-05-27

Published Print: 2021-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Einecke, Dirk
License Information

Text and Data Mining valid from 2021-05-01

Version of Record valid from 2021-05-01
More Information

Article History

First Online: 27 May 2021

Free to read: This content has been made available to all.